A detailed history of Vision Financial Markets LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Vision Financial Markets LLC holds 100 shares of MRNA stock, worth $3,361. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100
Holding current value
$3,361
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 06, 2025

BUY
$36.85 - $63.93 $3,685 - $6,393
100 New
100 $4.16 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $13.1B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Vision Financial Markets LLC Portfolio

Follow Vision Financial Markets LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vision Financial Markets LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vision Financial Markets LLC with notifications on news.